Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-234-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110216.11.3-234-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"I should like to offer my congratulations on the excellent work carried out by Mrs Matias. Falsified medicinal products are ‘silent killers’, even if they have no effect, because they contain toxic substances that can damage or even kill those who take them. The absence of a framework law encourages falsification, which is an organised crime.
We have seen disproportionate growth of this criminal activity, with a 400% increase in seizures of falsified medicinal products since 2005. It is estimated that 1% of the medicinal products currently on sale to the European public through the legal supply chain are falsified and that this number is increasing. In other parts of the world, more than 30% of the medicines on sale may have been falsified. In addition, increasing numbers of innovative and life-saving drugs are falsified.
We have therefore approved today a new law to prevent the entry of falsified medicines into the legal supply chain and to protect patient safety. The legislation also covers Internet sales and introduces new safety devices and traceability measures, as well as penalties for counterfeiters, to prevent the sale of falsified medicines to European Union citizens."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples